Background During the last decade, most of Latin American and the Caribbean (LAC)
countries have implemented oral live rotavirus vaccines in their national vaccination …

Acute diarrhea caused by rotavirus has an important impact on public health worldwide,
especially in low-and middle-income countries in which more than 90% of deaths in young …

Abstract Background Group A rotaviruses (RVA) are the most frequent single etiological
agents of severe diarrhea in infants. Since 2006 RVA vaccines have been introduced in …

Abstract Group A rotaviruses (RV‐A) are the leading cause of severe gastroenteritis in
infants and young children worldwide. Due to the epidemiologic complexity of RV‐A …

Background: A live, attenuated, pentavalent rotavirus vaccine (RV5) was introduced in
Nicaragua in 2006 through a 3-year partnership between Merck & Co, Inc., and the …

Epidemiological data on species A rotavirus (RVA) infections have demonstrated the genetic
diversity of strains circulating worldwide. Many G and P genotype combinations have been …

Background: Latin America will likely be the first area in the developing world where
rotavirus vaccine will be introduced into the routine childhood immunization schedule. In …

Rotavirus G1 strains represent the most common genotype that causes diarrhea in humans
and has been incorporated into both, monovalent and multivalent, rotavirus licensed …

To describe the circulation dynamics of human rotavirus genotypes in a region of southern
Europe over a 13-year period. The G-and P-types of rotavirus isolates of patients aged less …

Abstract Introduction In 2015, Argentina included Rotarix™ monovalent vaccine for universal
administration and it showed a sharp decline in all-cause and rotavirus-confirmed cases as …